2026-06-12 Hosts Jane Myles and Jean Sposaro were joined by Rachel McGovern (Boehringer Ingelheim) who shared how a simple but powerful “mock trial walkthrough” helped uncover protocol and operational challenges before a clinical trial ever enrolled a patient. By simulating key study visits from both patient and site perspectives, Rachel and her team identified opportunities to reduce burden, improve workflows, and strengthen protocol feasibility.

The conversation explores lessons learned from the simulation, the value of incorporating site and patient insights earlier in protocol development, and how operational testing can improve recruitment, study execution, and overall trial success. Rachel also discusses the challenges and opportunities of scaling this approach across organizations and therapeutic areas, making a compelling case for protocol simulations as a best practice in clinical research.

You can join TGIF-DTRA Sessions live on LinkedIn Live on Friday's at 12:00 PM ET by checking out our LinkedIn. Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and X. Learn more about Membership options and our work at www.dtra.org.